Living With is a health technology company offering a pocket-friendly and simple patient management application that allows medical professionals treat and track patients remotely. The app aims to revolutionise the way doctors and hospitals access digital tools to treat patients while collecting data for medical device and pharma companies. The company owns Squeezy (a popular paid medical app in the UK) and already has five products in 17 NHS Trusts. Living With also has a contract with one of the world’s greatest medical device companies. Living With will use the proceeds to give 5 data (drug/device) and 50 access customers (clinic/doctor), become HIPAA compliant for the US and to quicken sales and marketing.
days to go:
Expired
investment:
£200,000
MedicSpot is a healthcare company that is aiming to revolutionise healthcare delivery by combining the advantages of online and offline care. The company provides patients at designated hospitals with diagnostic tools like a stethoscope, oximeter, blood pressure monitor and thermometer which, in turn, is connected to the MedicSpot network. Onboard General Physicians (GPs) engage in live sessions with patients, guide them on how to use the tools, and perform a variety of diagnoses like listening to a patient’s heart and lungs, looking down their throat and into their ears, taking their blood pressure and oxygen readings, and measuring their body temperature. The company is also expanding into another subsidiary, Arc Health, which it claims will perform the aforementioned tasks with more efficiency and accuracy. The company will use the investment to increase the number of Medicspot clinics to 1,000, gain further NHS market share, launch a corporate business model and allow international pilots to take place.
days to go:
Expired
investment:
£1,048,396
Grocemania is an on-demand delivery platform, which allows customers to find and shop from local grocery stores and receive deliveries in minutes for only £2.50 at absolutely no cost to retailers. The company asserts that its team has been at the forefront of the pandemic delivering everyday essentials to thousands of people across London, Brighton, and Bristol in the UK. Grocemania has helped local retailers to generate £200,000 in sales through its platform since January 2020. It has allowed brands to subscribe and get detailed data analytics and sales insights about their products through its 'Data Reporting' module, and partnered with PepsiCo to maximize PepsiCo, Walkers, and Doritos sales during the UEFA Champions League Group Stage 2020. The company has featured in Timeout, The Grocer, Food Navigator, eMarketer, and UK Technews. It will use the investment to boost marketing and grow its monthly budget by 10 times, test its data module with current partnerships and create useful case-studies to secure more contracts, and invest more in local and product SEO.
days to go:
Expired
investment:
£173,781
Innis & Gunn is a leading craft brewer who is building Edinburgh's biggest brewery. The company has sold 21 million pints of beer in more than thirty countries, and its lager is a leading craft beer in Scotland. It has witnessed a turnover of 21 million in 2018. It is operating in over 30 countries. Innis & Gunn had secured £15m private equity backing in 2017. The proceeds will be used for the construction of large scale brewery which will secure the company's growth capacity and its future in Edinburg.
days to go:
Expired
investment:
£3,300,404
blend my day creates, produces and delivers delicious and nutritionist-approved wholefood breakfasts which can be freshly prepared in under a minute. Its product range consists of an assortment of entities from its ready-to-blend smoothies to ready-to-soak oats bowls. The company's products are 100% plant-based, gluten-free and dairy-free. blend my day argues that the breakfast market is worth £20 billion in the UK and France alone. It wants to become the leading healthy breakfast subscription service in the UK and Europe. The company has sold 20,000 products to date, has an Instagram following of 10,000, and is a part of '1% For the Planet' enterprise pledging to give 1% of all its sales to environmental organisations. blend my day will use the investment to launch a subscription plan to drive repeat purchase and lifetime value, invest in marketing campaigns, build its growth and operations team in the UK, and launch its foodservice range.
days to go:
Expired
investment:
£189,692
Agua de Madre is craft-brewed water kefir aimed at the evergrowing no- and low- alcohol UK market. It aims to be an ethical brand that makes a delicious drink with live bacteria up to 250 billion live cultures per 100ml. The naturally low-alcohol fizzy water kefir is sold in deli's, restaurants, bars, and other food stores in London. Agua de Madre has also attracted media interest from major publications including Metro, Vogue, and Wallpaper. Furthermore, the company is planning to maximise its production potential, hire a specialist sales agency Windfall, expand to sell further in southwest London, and ramp up marketing with its PR Agency, Visible.
days to go:
Expired
investment:
£250,990
The Cauldron is a technology-led entertainment studio that aims to deliver immersive experiences to its guests by combining technology with food and drink. Upon entering the company's venues, guests are given a magic wand, which acts as a control device for their visit. It helps them pour pints, activate lights and locks, explore science experiments, and stir cocktails. The device is also programmed to act as an open bar tab to track user spending. The Cauldron has served 1 million potions till date and welcomed 260,000+ guests. It has also inked ticket and product selling partnerships with entities like TimeOut, Airbnb Experiences, Secret London, Virgin Experience Days, and others. The company has featured on publications like Thrillist, NBC, Forbes, and Edinburgh News. The Cauldron will use 70% of the investment to open a central-London Cauldron flagship and provide additions to Wands & Wizard Exploratorium, 20% to finish the build for three new pop-up venues to open in markets across the US and Europe, and 10% to pay staff salaries.
days to go:
Expired
investment:
£304,690
NGX is the world’s first genetically personalised nutrition shake designed to bring nutrition to everyday athletes. The company has ongoing discussions to form partners with U.A.E and U.S to expand. NGX's nutritionist approved formula is a less than average vegan-friendly, environmentally responsible, allergen-free, naturally sourced, and macro trends within the millennial and Z generations. With the proceeds, the company aims to create a range of products from personalised meal plans, and protein bars to enhance its position as the go-to personalised nutrition brand.
days to go:
Expired
investment:
£207,860
Cranes Drinks is the fastest growing cider company in the UK, producing a range of innovative fruit ciders. By utilising the fruit’s natural sweetness, its drinks contain 30% fewer calories compared to that of brand leaders. Cranes ciders come in 3 flavours: blueberry & apple, cranberry & lime, and raspberry & pomegranate. As per Cranes, 34% of cider drinkers haven't consumed cider drinks much because it’s too sweet or has too much sugar. This makes Cranes a top contender in a growing fruit cider market worth £1.3 billion. The company's entire range is available on Ocado, and it has received 3 national listings in prominent retail chains like Sainsbury’s, Asda, and Morrisons. The brand has won 3 awards for its spirit range including a Gold Award in the Liqueur Masters organised by The Spirits Business and two awards from the International Wine & Spirits Competition. It has also received substantial media coverage in publications like Made In Chelsea, Dragons Dens, The Daily Telegraph, The Evening Standard, Vogue, Cosmopolitan, and Bella amongst others. With the investment, the company aims to use 25% of it as working capital, 60% in marketing, and 15% in managing key finances.
days to go:
Expired
investment:
£246,046
Quin is a mobile medical app that combines daily life experience with data from diabetes devices and phones and helps people decide how much insulin to take and when. They are on a mission to help people with insulin-treated diabetes make the best possible decisions through their app. The company have received a UK research and innovation grant. Apple has granted them insider access to their engineers and executives who are helping to get Quin to market, their app has a class I CE Mark, with two patents pending. With the investment, they will hire a product designer to enhance the user experience, achieve certification and compliance with new European Medical Device Regulations, develope B2B2C distribution partnerships and launch the Quin app in the UK and Europe in late 2020.
days to go:
Expired
investment:
£691,497
